Francesca Lawson
Publications by Year
Research Areas
Diabetes Treatment and Management, Cardiovascular Function and Risk Factors, Diabetes Management and Research, Nausea and vomiting management, Blood Pressure and Hypertension Studies
Most-Cited Works
- → Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome(2015)2,293 cited
- → Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy‐induced nausea and vomiting(2003)566 cited
- → Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer(2012)526 cited
- → Single-dose aprepitant vs ondansetron for the prevention of postoperative nausea and vomiting: a randomized, double-blind Phase III trial in patients undergoing open abdominal surgery †(2007)160 cited
- → Differential effects of glucagon-like peptide-1 receptor agonists on heart rate(2017)152 cited
- → Role of B‐Type Natriuretic Peptide and N‐Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus(2017)120 cited
- → Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus(2020)101 cited
- → Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo(2015)98 cited
- → Venous Thromboembolism (VTE) Prevention with Semuloparin in Cancer Patients Initiating Chemotherapy: Benefit-Risk Assessment by VTE Risk in SAVE-ONCO(2011)54 cited